THE Therapeutic Goods Administration advises health professionals and consumers that the short supply of EpiPen 300 mcg adrenaline auto-injectors has finally been resolved.
The sponsor, Alphapharm Pty Ltd (trading as Mylan Australia), has confirmed that there is sufficient supply of EpiPen 300 mcg adrenaline auto-injectors to meet current patient needs in Australia.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 19